Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9NVH0
UPID:
EXD2_HUMAN
Alternative names:
3'-5' exoribonuclease EXD2; Exonuclease 3'-5' domain-like-containing protein 2
Alternative UPACC:
Q9NVH0; B4DIH6; G5E947; Q6AWB6; Q8N3D3
Background:
Exonuclease 3'-5' domain-containing protein 2, also known as EXD2, exhibits critical enzymatic activities, including 3'-5' exoribonuclease and exodeoxyribonuclease, influenced by the presence of Mg(2+) or Mn(2+). Its role extends to mitochondrial function, ATP production, and mitochondrial translation, alongside a pivotal involvement in DNA damage response and chromosomal break repair.
Therapeutic significance:
Understanding the role of Exonuclease 3'-5' domain-containing protein 2 could open doors to potential therapeutic strategies.